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SUMMARY STATEMENT 
 
We demonstrate that LAR, a receptor tyrosine phosphatase, signals via CDK1 to promote 
adhesion complex formation and adhesion to extracellular matrix.  
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ABSTRACT 
 
Focal adhesions are complex multi-molecular structures that link the actin cytoskeleton to 
the extracellular matrix via integrin adhesion receptors and play a key role in regulation of 
many cellular functions. LAR is a receptor protein tyrosine phosphatase that regulates 
PDGF signalling and localises to focal adhesions. We have observed that loss of LAR 
phosphatase activity in mouse embryonic fibroblasts results in reduced numbers of focal 
adhesions and decreased adhesion to fibronectin. To understand how LAR regulates cell 
adhesion we used phosphoproteomic data, comparing global phosphorylation events in 
wild type and LAR phosphatase-deficient cells, to analyse differential kinase activity. 
Kinase prediction analysis of LAR-regulated phosphosites identified a node of 
cytoskeleton- and adhesion-related proteins centred on cyclin-dependent kinase-1 (CDK1). 
We found that loss of LAR activity resulted in reduced activity of CDK1, and that CDK1 
activity was required for LAR-mediated focal adhesion complex formation. We also 
established that LAR regulates CDK1 activity via c-Abl and PKB/Akt. In summary, we 
have identified a novel role for a receptor protein tyrosine phosphatase in regulating CDK1 
activity and hence cell adhesion to the extracellular matrix.  
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INTRODUCTION  
 
Traditionally, phosphatases have been considered relatively non-specific regulators of 
cellular signalling pathways, a view that has been increasingly challenged in recent years. 
It is now clear that phosphatases play very specific roles in both the positive and negative 
propagation of signals (Tonks, 2013). Leukocyte common antigen-related (LAR), also 
known as receptor type protein tyrosine phosphatase F (PTPRF), is a receptor protein 
tyrosine phosphatase. It is comprised of an extracellular domain that contains three 
immunoglobulin domains and eight fibronectin type III domains in addition to two 
cytoplasmic phosphatase domains, D1 and D2 (Chagnon et al., 2004). LAR is expressed in 
a number of human tissues including brain, heart and bladder, and LAR-deficient mice are 
characterised by axon guidance defects, diabetes, neuron degeneration, cancer and 
abnormal development of mammary glands (Chagnon et al., 2004; Van Lieshout et al., 
2001). Previous work has identified roles for LAR in neuronal growth and regeneration, 
mammary gland development and in mitogenic signalling via the PDGF receptor  
(PDGFR) (Schaapveld et al., 1997; Um and Ko, 2013; Zheng et al., 2011). 
 
Cell interaction with the extracellular matrix is mediated in part through complex, dynamic 
multi-molecular structures called focal adhesions that link the actin cytoskeleton to the 
extracellular matrix via integrin adhesion receptors (Wehrle-Haller, 2012). Focal 
adhesions mediate transfer of signals from the extracellular matrix to the cytoplasm and 
nucleus, regulating many functions including proliferation, apoptosis, differentiation and 
cell migration (Wehrle-Haller, 2012). Proteins localizing to focal adhesions include 
structural proteins that link integrins to the actin cytoskeleton as well as many other 
proteins involved in signal transduction. These include the well-documented regulators of 
focal adhesions, Src and focal adhesion kinase (FAK) but also other kinases including 
members of the cyclin-dependent kinase (CDK) family (Horton et al., 2015; Robertson et 
al., 2015; Zaidel-Bar et al., 2007). The extracellular domain of LAR is known to interact 
with components of the extracellular matrix including the laminin–nidogen complex and 
syndecan (Johnson et al., 2006; O'Grady et al., 1998) and imaging and proteomic studies 
have established that LAR is a component of focal adhesions and can regulate the actin 
cytoskeleton (Serra-Pages et al., 1995; Zaidel-Bar et al., 2007).  
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However, whilst LAR is known to localise to focal adhesions and interact with 
components of the extracellular matrix, its role in cell adhesion has not been established. 
To analyse the role of LAR in cell adhesion we used wild-type (WT) mouse embryonic 
fibroblasts (MEFs) and MEFs in which the LAR phosphatase domains have been deleted 
(LARΔP) (Schaapveld et al., 1997). Our results reveal a novel signalling pathway in which 
LAR phosphatase signals via c-Abl, Akt and CDK1 to regulate adhesion complex 
assembly and optimal adhesion to fibronectin.  
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RESULTS 
 
Focal adhesion formation is significantly decreased in cells lacking LAR 
phosphatase activity.  
LAR localises to adhesion complexes and is known to regulate the actin cytoskeleton 
(Bateman et al., 2001; Serra-Pages et al., 1995). Therefore, we evaluated the role of 
LAR in adhesion complex formation and adhesion to extracellular matrix. To do this 
we used mouse embryo fibroblasts (MEFs) expressing either wild type LAR (WT) or a 
truncated form of LAR lacking phosphatase activity (LARP) (Schaapveld et al., 
1997). Following serum starvation, cells were either unstimulated or stimulated with 
PDGF BB, a well-established regulator of adhesion complex formation (Ridley et al., 
1992), for 14 minutes prior to fixation and staining using an anti-phospho-paxillin 
(Tyr
118
) antibody to visualise adhesion complexes (Burridge et al., 1992). We observed 
a significant decrease in phospho-paxillin staining in unstimulated LARP cells when 
compared to WT cells (Figure 1A, B, E). Treatment with PDGF BB resulted in 
increased phospho-paxillin staining in both LARP and WT cells but again there was a 
significant decrease in adhesion complexes in LARP cells compared to WT cells 
(Figs 1C-E). 
 
The extracellular matrix protein fibronectin is secreted by fibroblasts and plays a key 
role in cell-extracellular matrix interactions during development and in wound healing 
(Hynes, 1994). In order to investigate whether LAR phosphatase activity contributes to 
these cell-extracellular matrix interactions, we used a standard adhesion assay to 
analyse attachment of WT and LARP MEFs to fibronectin. Serum-starved WT and 
LARP cells were allowed to attach to fibronectin in the presence or absence of 20ng 
mL
-1
 PDGF BB for 30 minutes. LARP cells were substantially impaired in their 
ability to attach to fibronectin when compared to WT cells, and this was apparent over 
a range of fibronectin plating concentrations between 0.5 and 10g mL-1 (Fig. 2A). 
Treatment with PDGF did not significantly affect attachment of either WT or LARP 
cells (Fig. 2A). To confirm these data, we used RNA interference to knockdown 
expression of LAR in WT cells (Fig. 2B). RNAi-mediated reduction of LAR 
expression in WT cells was accompanied by a significant decrease in cell attachment to 
10g mL-1 fibronectin when compared to WT cells transfected with a non-silencing 
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control (NSC) oligo  (Fig. 2C). Having observed that LAR regulated adhesion complex 
formation and attachment to fibronectin we analysed cell migration of WT and LARP 
cells, using a standard scratch wound assay. We found that loss of LAR phosphatase 
activity did not affect cell migration, with both WT and LARP cells closing wounds 
at equivalent rates  (Fig. 2D). We conclude that LAR phosphatase regulates adhesion 
complex formation and attachment to fibronectin in mouse embryonic fibroblasts but 
has no effect on cell migration. 
 
Regulation of adhesion complexes by LAR is independent of focal adhesion kinase 
activity. 
Focal adhesion kinase (FAK) and Src are non-receptor tyrosine kinases frequently 
linked to adhesion complex dynamics, cell adhesion and cell migration (Mitra and 
Schlaepfer, 2006), although recent data also report that adhesion complex composition 
is unaffected when Src and FAK are inhibited (Horton et al., 2016). Tyr
118
 of paxillin 
is a known FAK substrate (Bellis et al., 1995), and we tested whether activation of 
FAK was affected in the absence of LAR activity. Autophosphorylation of Tyr
397
 is a 
key stage in activation of FAK, creating a docking site for the recruitment and 
activation of the non-receptor tyrosine kinase Src which subsequently phosphorylates 
FAK on Tyr
407
 (Calalb et al., 1995). Consistent with immunostaining of adhesion 
complexes (Fig. 1) we observed substantially reduced paxillin Tyr
118
 phosphorylation 
in LARP cells when compared to WT cells, both in the absence and presence of 
PDGF (Fig. 3A). However, when we analysed FAK activity in LARP cells we 
observed no significant difference in phosphorylation of either Tyr
397
 or Tyr
407
 when 
compared to WT cells (Figs 3B-D). These data are consistent with the previous 
observation that activation of Src is not regulated by LAR (Zheng et al., 2011) and 
indicate that the decreased phosphorylation of paxillin and reduced adhesion complex 
formation seen in LARP cells are not a consequence of altered FAK signalling.  
 
Phosphoproteomic analysis of LARP cell signalling identifies a role for LAR 
phosphatase in regulation of CDK1 
To identify key signalling events regulated by LAR we analysed our comparative (WT 
versus LARP MEFs) global phosphoproteomic dataset (deposited in the 
ProteomeXchange Consortium via the PRIDE partner repository 
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(www.ebi.ac.uk/pride/archive dataset identifier PXD002545) (Sarhan et al., 2016). 
Within this dataset, we identified altered phosphorylation of 270 phosphorylation sites 
in 205 proteins in PDGF-BB stimulated LARP cells when compared to WT cells. To 
identify key nodes of regulation within the dataset, the kinase prediction tool GPS  
(Xue et al., 2008) was used to identify putative kinases upstream of the 270 identified 
phosphorylation motifs. A cluster of 38 proteins containing predicted cyclin dependent 
kinase 1 (CDK1) phosphorylation motifs were identified with significantly reduced 
phosphorylation in LARP cells. Of these, 19 (50%) form part of the recently 
characterised meta-adhesome (Horton et al., 2015) (Fig. 4A).  
 
Phosphorylation of Thr
161
 in the activation loop of CDK1 is a key step in activation of 
the kinase (Krek and Nigg, 1992; Solomon et al., 1992), therefore we used a phospho-
specific antibody to analyse activation of CDK1 in WT and LARP cells. In serum-
starved WT cells, basal phosphorylation of CDK1 Thr
161
 was observed and this 
increased on addition of PDGF (Fig. 4B). In contrast, the basal phosphorylation of 
Thr
161
 in LAR∆P cells was lower than in WT cells and no increase in phosphorylation 
of Thr
161 
was observed when cells were treated with PDGF (Fig. 4B). CDK activity 
requires interaction with a partner cyclin and CDK1 forms a complex with cyclin B1 
during G2/M (Malumbres, 2014) but no difference in expression of CDK1 or cyclin 
B1, or association between CDK1 and cyclin B1, was observed when LARP cells 
were compared to WT cells (Fig. 4C). This suggests the decrease in CDK1 activity in 
LAR∆P cells was not a consequence of cyclin availability. 
 
In the absence of LAR phosphatase activity we have observed decreased 
phosphorylation  of CDK1 consistent with decreased activity and have identified a 
cluster of potential adhesion-related CDK1 substrates. CDK1 has recently been linked 
to cell adhesion (Robertson et al., 2015), thus we next examined the role of CDK1 in 
LAR-dependent cell adhesion. Treatment of WT MEFs with the CDK1 inhibitor, RO-
3306, resulted in significantly fewer focal adhesions, consistent with CDK1 regulating 
adhesion complex formation in this cell type (Figs 4D, E). To confirm that CDK1 
regulates adhesion complexes in MEFs downstream of LAR we transiently expressed a 
constitutively active form of CDK1 (CDK1 AF) in LARP cells. This resulted in a 
significant increase in adhesion complex formation (Figs 4F, G). These data establish 
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CDK1 as a protein kinase acting downstream of LAR to regulate adhesion complex 
formation. 
 
LAR signals to CDK1 via Akt 
Previous work has shown that LAR regulates PDGF-mediated activation of Akt 
(Zheng et al., 2011) and loss of Akt activity is associated with decreased 
phosphorylation of CDK1 at Thr
161
 (Nogueira et al., 2012), suggesting that Akt may be 
part of the pathway downstream of LAR leading to activation of CDK1 and regulation 
of adhesion complex formation. 
 
To investigate whether Akt is involved in LAR-dependent cell adhesion we analysed 
adhesion complex formation in WT cells treated with an Akt inhibitor (InSolution Akt 
Inhibitor VIII) and observed a significant (p<0.001) decrease in adhesion complex 
formation compared to control, vehicle (DMSO) treated cells (Fig. 5A). Activation of 
Akt requires phosphorylation of Thr
308
 in the activation loop (Alessi et al., 1996), and 
consistent with previously published data that PDGFR-induced activation of Akt is 
dependent on LAR (Zheng et al., 2011), we observed a rapid increase in 
phosphorylation of Akt Thr
308
 in control, serum-starved WT cells, treated with PDGF 
(Figs 5B, C) and significantly reduced phosphorylation of Thr
308
 in LAR∆P cells at all 
time points (Figs 5B, C). Treatment of WT cells with the Akt inhibitor, in the absence 
or presence of PDGF, also resulted in a significant reduction in Thr
161
 phosphorylation 
of CDK1 (Fig. 5D) confirming Akt-dependent regulation of CDK1 activity in MEFs. 
This provides further evidence for a novel role of LAR in regulation of cell adhesion 
via CDK1.  
 
Inhibition of c-Abl restores activation of Akt and CDK1 in cells lacking LAR 
phosphatase activity. 
Previous work has reported hyper-phosphorylation of the tyrosine kinase c-Abl in 
LARP cells and Abl has been identified as a potential substrate for the Drosophila 
LAR ortholog, DLAR (Wills et al., 1999; Zheng et al., 2011). In mammalian cells a 
large number of c-Abl substrates have been identified, many of which are involved in 
regulation of cell adhesion and the actin cytoskeleton (Wang, 2014; Woodring et al., 
2003). To establish whether c-Abl is a LAR substrate we transfected 293T cells with 
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cDNA constructs expressing either WT LAR or one of two LAR substrate trapping 
mutants - LAR C/S (C1548S) or LAR D/A (D1516A) (Fig. 6A) (Wang et al., 2007). 
These mutations within the intracellular phosphatase domain D1 allow LAR to interact 
with substrates but reduce its dephosphorylation activity (Wang et al., 2007). Using 
this approach, we identified that both the LAR trapping mutants and WT LAR 
interacted with c-Abl (Fig. 6B). When compared to cells transfected with either 
trapping mutant, a reduction in tyrosine phosphorylation was observed in c-Abl bound 
to WT LAR (Fig. 6B). These data identify c-Abl as a LAR substrate. To determine 
whether c-Abl is involved in LAR-mediated regulation of CDK1 we treated LARP 
cells with AG957, a selective inhibitor of c-Abl (Anafi et al., 1992), and examined the 
effect of inhibiting c-Abl on activation of Akt and CDK1. Inhibition of c-Abl in 
LAR∆P cells resulted in significantly increased phosphorylation of both Akt Thr308 and 
CDK1 Thr
161
 (Figs 6C-F). These data indicate that c-Abl is a key component of the 
LAR pathway upstream of Akt and CDK1.  
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DISCUSSION 
 
Much of what we currently know about LAR function focuses on its role in the 
nervous system and comes from work on the Drosophila ortholog, DLAR (Um and Ko, 
2013). DLAR localises to synaptic junctions and regulates synaptic growth and axonal 
guidance through regulation of the actin cytoskeleton via Rho family GTPases 
(Bateman et al., 2000; Kaufmann et al., 2002; Pawson et al., 2008). Outside of the 
nervous system relatively little is known about LAR function, although DLAR has 
been reported to regulate the actin cytoskeleton in Drosophila epithelia (Bateman et al., 
2001; Conder et al., 2007). In addition, in mammalian cells an interaction between 
LAR and EphA2 has been reported to be important for cell migration (Lee and 
Bennett, 2013). Our data, showing decreased adhesion complex formation and 
decreased cell adhesion to extracellular matrix in the absence of LAR phosphatase 
activity, identify LAR as a regulator of cell adhesion to extracellular matrix in 
mammalian cells. Furthermore we identify that LAR affects cell adhesion through 
regulation of CDK1 activity.  
 
Kinase prediction analysis of LAR-regulated phosphosites identified a node of 
cytoskeleton- and adhesion-related proteins centred on CDK1 (Fig. 4), 50% of which 
form part of the recently characterised meta-adhesome (Horton et al., 2015). Most 
work has focused on nuclear functions for CDKs, and the role of CDK1 in regulating 
the G2/M cell cycle transition is well established (Malumbres, 2014). However, there 
is increasing evidence from both imaging and proteomic studies to support the 
hypothesis that CDKs have significant non-nuclear roles. CDK1 has been identified as 
being present in focal adhesions and recent data indicates that CDK1, along with other 
CDKs, plays a role in integrin-based cell adhesion and motility (Manes et al., 2003; 
Robertson et al., 2015). During G2/M transition in vertebrates, phosphorylation of 
CDK1 Thr
161
 is a function of CDK7, a CDK activating kinase (CAK) and one 
possibility is that LAR might also regulate CDK7 activity.  (Desai et al., 1995; Fisher, 
2005). However, analysis of our phosphoproteomics dataset (Sarhan et al., 2016) did 
not reveal any significant change in phosphorylation of Ser
164
 which is required for 
activation of CDK7 (Larochelle et al., 2001). This suggests LAR may be regulating 
phosphorylation of Thr
161
 and activation of CDK1 in a CDK7-independent manner. 
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 We have identified that the tyrosine kinase c-Abl is a direct substrate for LAR in 
mammalian cells and a key component linking LAR phosphatase to CDK1. Consistent 
with these findings, c-Abl localises to adhesion complexes and the Drosophila ortholog 
of LAR, DLAR, is known to interact with Abl to regulate axon guidance, an actin- and 
adhesion-dependent process (Wills et al., 1999; Zaidel-Bar et al., 2007). The question 
remains as to how c-Abl is regulating CDK1 activity and our data indicate this is 
achieved via Akt as we observed that inhibition of Akt blocked LAR-dependent 
activation of CDK1 (Fig. 5D). As LAR has been reported to regulate PDGF signalling 
via c-Abl (Zheng et al., 2011) and Akt is well-established as a signalling component 
downstream of receptor tyrosine kinases including PDGFR (Andrae et al., 2008), one 
possible explanation for our findings is that LAR regulates CDK1 and hence cell 
adhesion via the PDGF pathway. The decreased Akt Thr
308
 phosphorylation seen in 
LARP cells following PDGF stimulation (Fig. 5B) would support this idea and Akt 
has also been reported to regulate PDGF-dependent phosphorylation of FAK at Tyr
397
 
(Higuchi et al., 2013). However, we find no evidence that LAR regulates FAK activity 
and phosphorylation of CDK1 Thr
161
 in LARP cells is not affected by PDGF (Fig. 
4B). In addition, we observe that LAR can regulate adhesion complex formation and 
cell adhesion independent of PDGF stimulation (Figs 1,2). One surprising observation 
was that whilst inhibition of c-Abl restored phosphorylation of CDK1 Thr
161
 in un-
stimulated LARP cells, thus identifying c-Abl as a component of the pathway linking 
LAR to activation of CDK1, stimulation with PDGF resulted in a steady decrease in 
CDK1 Thr
161
 phosphorylation over time. One possible explanation for this is that in the 
absence of LAR and c-Abl activity a phosphatase is activated that can dephosphorylate 
CDK1. Irrespective of this, our data clearly demonstrate a role for c-Abl in regulating 
LAR-mediated phosphorylation of CDK1 and taken together, our data indicate that 
whilst PDGF signalling can act to modulate LAR-dependent effects on adhesion, LAR 
can also regulate CDK1 and cell adhesion independent of PDGF signalling (Fig. 7).  
 
We have observed that LAR positively regulates attachment to fibronectin and, whilst 
there is no evidence for LAR interacting directly with fibronectin, LAR has been 
reported to interact with the laminin-nidogen complex (O'Grady et al., 1998). This 
would suggest that LAR might play a role in regulating both ‘inside-out’ and ‘outside-
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in’ signalling in a manner analogous to integrins (Hynes, 2002) and it would be 
interesting to analyse whether different extracellular matrix substrates elicit distinct 
LAR-dependent signalling events. Interestingly, whilst we have clear evidence that 
LAR regulates cell adhesion, loss of LAR activity had no effect on cell migration (Fig. 
2). This would be consistent with our data showing that LAR does not affect activity of 
FAK (Fig. 3), a known regulator of cell migration in fibroblasts (Sieg et al., 1999).   
Given the ability of LAR to regulate both PDGF-dependent mitogenic signalling and 
adhesion to extracellular matrix it is tempting to speculate that LAR may play a pivotal 
role in integrating signals required for cell cycle progression. Similarly, LAR might 
also be important in anoikis, where detachment of a normal, adherent cell is a prelude 
to programmed cell death (Reddig and Juliano, 2005). 
  
In summary, we have identified a novel mechanism whereby a membrane associated 
protein tyrosine phosphatase positively regulates adhesion complex formation and cell 
adhesion via a signalling pathway involving c-Abl, Akt and CDK1.  
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MATERIALS AND METHODS 
Antibodies 
Akt (#9272), phospho-Akt Thr
308
 (#9275), cyclin B1 (#4135), paxillin (#2542), 
phospho-paxillin Tyr
118
 (#2541), phospho-CDK1 Thr
161
 (#9114) and c-Abl (#2862) 
antibodies were obtained from Cell Signaling Technology (Danvers, MA). CDK1 (#sc-
54), phospho-FAK Tyr
407
 (#sc-16664) and PY99 phosphotyrosine (#SC-7020) 
antibodies were obtained from Santa Cruz Biotechnology (Dallas, TX). FAK 
(#610087) and phospho-FAK Tyr
397
 (#611722) antibodies were purchased from BD 
Biosciences (Franklin Lakes, NJ). FLAG M2 antibody (#F3165) was from Sigma-
Aldrich (Poole, UK). LAR antibody (#73-193) was purchased from Neuromab (UC 
Davis, CA). The Alix antibody was a gift from Carl Hendrik Heldin (Karolinska 
Institute, Sweden) (Lennartsson et al., 2006). Alexa 594-conjugated phalloidin and 
DAPI were from Life Technologies (Paisley, UK). Goat anti-mouse IgG IRDye-
conjugated antibody and goat anti-rabbit IgG HRP-conjugated antibodies were from 
LI-COR Biosciences (Lincoln, NE). 
 
Cell Culture  
All cells were grown in DMEM supplemented with 10 % fetal bovine serum (FBS), 
100 U/mL penicillin, 10 mg mL
-1
 streptomycin, and 250 μg mL-1 amphotericin B and 
periodically tested for, and shown to be free of, mycoplasma contamination. WT and 
LARΔP mouse embryonic fibroblasts (MEFs) were kind gifts from Wiljan Hendriks 
(Radbound University Medical Centre, Netherlands) (Schaapveld et al., 1997). Cell 
culture reagents were purchased from Gibco Life Technologies (Paisley, UK). For 
growth factor stimulation experiments cells were grown to 80 % confluence and 
starved for 16 hours in serum free DMEM before being treated with 20 ng mL
-1
 
recombinant PDGF-BB (Cell Signaling Technology) at 37 ˚C. In some experiments, 
cells were incubated with 10 μM InSolution Akt Inhibitor VIII (Barnett et al., 2005) 
(Merck Millipore, Watford UK) to inhibit Akt, 10 μM AG957 (Sigma-Aldrich, Poole 
UK) to inhibit c-Abl or RO-3306 (Merck Millipore, Watford UK) to inhibit CDK1. 
The carrier DMSO was added to control cells.  
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Cell lysis, immunoprecipitation and immunoblotting 
Cell lysates were prepared, separated by SDS-PAGE, transferred to nitrocellulose 
membranes and immunoblotted using previously described protocols (Zheng et al., 
2011). Immunoblots were visualized using fluorescence detection on the Odyssey 
Infrared Imaging System (LI-COR Biosciences, Lincoln NE). Densitometric analysis 
was carried out using ImageJ. Immunoprecipitation of cyclin B1 or CDK1 using 
Dynabeads protein G (Novex, Life Technologies) was performed as per the 
manufacturer's protocol. 
 
Cell adhesion and scratch wound assays 
Adhesion assays were performed as described previously (Lock and Hotchin, 2009) 
with the modification that adherent cells were quantitated by addition of 5 mg mL
-1
 of 
Thiazolyl blue tetrazolium bromide (MTT) (Sigma-Aldrich, Poole UK) for 1 hour at 37 
˚C followed by addition of 100 μL of isopropanol for 15 minutes at room temperature 
after which absorbance was measured at 570 nm. For the scratch wound assays, cells 
were plated in 96 well cell culture plates and cultured to confluency. Scratch wounds 
were made using an automated wound maker (Essen BioScience, Hertfordshire, UK) 
and images collected at hourly intervals post-wounding using an IncuCyte ZOOM 
imaging system (Essen BioScience, Hertfordshire, UK). 
 
Immunocytochemistry 
WT and LARΔP cells were grown on acid-etched glass coverslips before being 
cultured overnight in serum-free medium. Where indicated, seeded cells were 
incubated with either 10 μM CDK1 RO-3306 specific inhibitor for one hour or 10 μM 
InSolution Akt Inhibitor VIII or in DMSO overnight. Cells were stimulated with 20 ng 
mL
-1
 PDGF-BB for 14 minutes and then incubated on ice for 5 minutes. Fixed and 
permeabilised cells were immunostained as previously described (Lock and Hotchin, 
2009). Cells were visualized using TIRF Nikon A1R confocal microscope with NIS-
Elements Software and images were analysed using ImageJ 1.48. To quantitate 
adhesion complex area, background-subtracted images of a minimum of 4 cells per 
experiment were thresholded to identify and measure adhesion pixels using ImageJ 
software using a previously published method (Webb et al, 2004).  
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RNA interference 
Cells were transiently transfected with 80 pmol of SMARTpool ON-TARGETplus 
siRNA for murine LAR (L-042444-00-0005; Dharmacon, Lafayette, CO) using 
Lipofectamine RNAiMAX (Life Technologies, Paisley UK) as described elsewhere 
(Lock and Hotchin, 2009). Non-silencing control (NSC) siRNA was used as a control 
for each experiment.  
 
cDNA expression 
To ‘rescue’ CDK1 activity, LARΔP cells were transiently transfected with a 
constitutively active form of CDK1 (CDK1-AF) (Hagting et al., 1998) using 
Lipofectamine 2000 (ThermoFisher Scientific) according to manufacturer’s 
instructions. In the LAR phosphatase trap experiment 293T cells were transiently 
transfected using Lipofectamine 2000 with cDNA constructs expressing either wild 
type c-Abl (WT c-Abl) (Johannessen et al., 2010) or WT LAR, LARC1538S (LAR 
C/S) or LARD1506A (LAR D/A) (Wang et al., 2007). The LAR constructs were 
kindly provided by Ruey-Hwa Chen (National Taiwan University, Taipei, Taiwan). 
The CDK1-AF construct was obtained from Addgene (Cambridge MA). 
 
Phosphoproteomics and bioinformatics 
Potential CDK1 substrates were identified using the Group-based Prediction System 
(GPS; version 2.1.2) (Xue et al., 2008). To minimize false positives, the highest 
threshold was applied. Protein-protein interaction (PPI) network analyses were 
performed using Cytoscape (version 3.3.0) (Shannon et al., 2003). GO enrichment 
analyses were performed using (DAVID; version 6.7) (Huang da et al., 2009). 
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Figures 
 
 
 
 
Figure 1: Loss of LAR phosphatase activity is associated with decreased adhesion 
complex formation. (A-D) WT and LAR∆P MEFs were serum-starved overnight 
before being cultured in the presence or absence of 20ng mL
-1
 PDGF BB for 14 
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minutes. Fixed and permeabilised cells were stained using an antibody against 
phosphorylated paxillin Tyr
118
 to visualise adhesion complexes. Nuclei were visualised 
using DAPI. Scale bar represents 20 m. (E) The cell area occupied by adhesion 
complexes was calculated using ImageJ and expressed as a percentage of the total cell 
area. Data presented in E are from 3 separate experiments with 4-5 representative cells 
analysed per experiment. Statistical significance was calculated by first normalising the 
data by arcsine transformation, followed by a one-way ANOVA with post hoc Tukey’s 
test (** p<0.01; *** p<0.001). 
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Figure 2: LAR phosphatase is required for optimal cell adhesion to fibronectin. 
(A) Serum-starved WT and LAR∆P MEFs were allowed to attach to fibronectin for 30 
minutes in the presence or absence of 20 ng mL
-1
 PDGF BB. Non-adherent cells were 
discarded and percentage cell attachment to increasing concentrations of fibronectin 
calculated. Data are the mean and standard error of 3 separate experiments.  (B, C) WT 
MEFs were transiently transfected with siRNA oligos targeted against LAR or with 
control non-silencing oligos (NSC). 48 hours after transfection cells were serum-
starved overnight and either (B) cell lysates were prepared for immunoblotting with 
antibodies against LAR and Alix (loading control) or (C) cells were allowed to attach 
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to 10 g mL-1 fibronectin for 30 minutes and percentage attachment calculated as 
described in A. Statistical significance was calculated by first normalising the data by 
arcsine transformation, followed by a Student’s T test. (D) WT and LAR∆P MEFs 
were wounded using an automated scratch maker and images of 5 separate wounds 
taken at 0, 5, 10 and 15 hours post wounding for each cell line using the IncuCyte 
ZOOM imaging system. Data are the mean and standard error of 3 separate 
experiments.  
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Figure 3: FAK tyrosine phosphorylation is unaffected by loss of LAR activity. (A, 
B) Serum-starved WT and LAR∆P MEFs were stimulated with 20 ng mL-1 PDGF BB 
for increasing periods of time before protein lysates were prepared and immunoblotted 
using antibodies against (A) paxillin (Pax) and phospho-paxillin Tyr
118
 or (B) FAK, 
phospho-FAK Tyr
397
 and phospho-FAK Tyr
407
. In both (A) and (B) expression of Alix 
was used as a loading control and results are representative of three independent 
experiments. (C, D) The ratio of either phosphorylated FAK Tyr
407 
(C) or 
phosphorylated FAK Tyr
397
 (D) to total FAK was calculated using densitometric 
analysis of immunoblots. Data are the mean and standard error from 3 separate 
experiments.   
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Figure 4: CDK1 functions downstream of LAR to regulate focal adhesion complex 
formation. (A) CDK1 substrates were analysed using the Group-based Prediction 
System (GPS). Of 270 phosphopeptides, 38 were identified as potential CDK1 
substrates. Protein-protein interaction network analyses were performed using 
Cytoscape. Nodes are clustered according to functional group and nodes identified as 
being part of the meta-adhesome are highlighted with a red border. (B) Serum-starved 
WT and LAR∆P MEFs were stimulated with 20 ng mL-1 PDGF BB for increasing 
periods of time before protein lysates were prepared and immunoblotted using 
antibodies against CDK1, CDK1 phospho-Thr
161
, cyclin B1 and Alix (loading control). 
Results are representative of three independent experiments. (C) Serum-starved WT 
and LAR∆P MEFs were stimulated with 20 ng mL-1 PDGF BB for 7 min, Cyclin B1 
immunoprecipitated and immunoblotted with CDK1 or Cyclin B1 (D) WT MEFs were 
treated with a CDK1 inhibitor (RO-3306) or DMSO (carrier control) for 60 minutes 
before being stimulated with 20 ng ml
-1
 PDGF-BB for 14 minutes, fixed and stained 
with a phospho-paxillin (Y
118
) antibody to visualise focal adhesions. Scale bar 
represents 20 m. (E) (G) The cell area occupied by adhesion complexes was 
calculated using ImageJ and expressed as a percentage of the total cell area. Data are 
the mean and standard error of 3 independent experiments with a minimum of 4 cells 
analysed per experiment. Statistical significance was calculated by first normalising the 
data by arcsine transformation, followed by a one-way ANOVA with post hoc Tukey’s 
test (*** p<0.001). (F) LARΔP cells were transfected with constitutively active form 
of CDK1 (CDK1-AF) before being stimulated with 20 ng mL
-1
 PDGF-BB for 14 
minutes, fixed and stained with a phospho-paxillin (Y
118
) antibody to visualise focal 
adhesions.  
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Figure 5: Akt is required for LAR-mediated regulation of CDK1 and adhesion 
complex formation. (A) WT MEFs cultured in normal growth medium were treated 
with an Akt inhibitor (InSolution Akt Inhibitor VIII) or DMSO (carrier control) 
overnight before being stimulated with 20 ng mL
-1
 PDGF-BB for 14 minutes, fixed 
and stained with a phospho-paxillin (Y
118
) antibody to visualise focal adhesions. The 
cell area occupied by adhesion complexes was calculated using ImageJ and expressed 
as a percentage of the total cell area. Data are the mean and standard error of 3 
independent experiments with a minimum of 4 representative cells analysed per 
experiment.  Statistical significance was calculated by first normalising the data by 
arcsine transformation, followed by a two-way ANOVA with Sidak’s test (*** p < 
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0.001). Scale bar represents 20 m. (B, C) Serum-starved WT and LAR∆P MEFs were 
stimulated with 20 ng mL
-1
 PDGF BB for increasing periods of time before protein 
lysates were prepared and immunoblotted using antibodies against Akt, phospho-Akt 
Thr
308
 and Alix (loading control). (C) Densitometric analysis of data from 3 
independent experiments using ImageJ. (D) Serum-starved WT MEFs were stimulated 
with 20 ng mL
-1
 PDGF BB for increasing periods of time in the presence of InSolution 
Akt Inhibitor VIII (Akt inhibitor) or DMSO (carrier control) before protein lysates 
were prepared and immunoblotted using antibodies against CDK1, phospho-CDK1 
Thr
161
 and Alix (loading control). 
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Figure 6: Inhibition of c-Abl restores phosphorylation of CDK Thr
161
 in cells 
lacking LAR phosphatase activity. (A) Schematic structure of LAR substrate-
trapping mutants. Full-length FLAG-tagged wild-type LAR (WT), substrate-trapping 
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mutants C/S (Cys1548 in D1 domain replaced by Ser1548) and D/A (Asp1516 in D1 
domain replaced by Ala1516). Ig, immunoglobulin-like domain; FNIII, fibronectin 
type III repeat domain; TM, transmembrane; D1, protein tyrosine phosphatase domain 
1; D2, protein tyrosine phosphatase domain 2. (B) FLAG-tagged wild-type LAR (WT) 
and substrate-trapping mutants of LAR along with WT c-Abl were either expressed 
alone or co-expressed in 293T cells. c-Abl was immunoprecipitated using a c-Abl-
specific antibody and immunoprecipitates were immunoblotted with either LAR, c-Abl 
or total phosphotyrosine (PY99) antibodies. To control for expression levels, whole 
cell lysates (WCL) were immunoblotted with FLAG antibody. (C, D) Serum-starved 
LARP cells were stimulated with 20 ng mL-1 PDGF BB for increasing periods of 
time in the presence of a c-Abl inhibitor (AG957) or DMSO (carrier control) before 
protein lysates were prepared and immunoblotted using antibodies against Akt, 
phospho-Akt Thr
308
 and Alix (loading control) (C) or CDK1, phospho-CDK1 Thr
161
 
and Alix (loading control) (D). For both CDK1 (E) and Akt (F) blots from 3 
independent experiments were analysed using ImageJ and statistical significance was 
calculated by first normalising the data by arcsine transformation, followed by a two-
way ANOVA with Sidak’s test (** p < 0.01; * p < 0.05). 
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Figure 7: Model showing how LAR phosphatase regulates cell adhesion via CDK1 
In wild type MEFs, LAR dephosphorylates and inactivates c-Abl resulting in enhanced 
Akt and CDK1 signalling, leading to increased cell adhesion to extracellular matrix 
(ECM). In the absence of LAR phosphatase activity, c-Abl inhibits Akt, resulting in 
decreased CDK1 activity and decreased cell adhesion to extracellular matrix. 
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